Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Piramal Pharma Financial Results

Piramal Pharma Limited reported its FY2026 audited financial results, showing standalone annual revenue of ₹4,782.01 Crore and PAT of ₹700.01 Crore. The Board also approved the re-appointment of Ms. Nandini Piramal as Chairperson and Mr. Peter DeYoung as Executive Director, alongside shifting the company's registered office and appointing a new Company Secretary.

Source

BSE filing, NSE: PPLPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Piramal Pharma Ltd: key numbers

Share price
₹232.80
Market cap
₹30,994 Cr
Revenue (annual)
₹8,869 Cr
Net profit (annual)
₹-325.9 Cr
P/E (TTM)
-148.4×Sector 46.1×
Promoter holding
34.80%+0.00% QoQ
FII holding
13.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Piramal Pharma Ltd

All →

Other financial results announcements

All →